Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shehata

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
BMC Neurology|February 4, 2021
The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in EgyptNirmeen A Kishk, Walaa Abdelfattah, Nevin M Shalaby, et al.
Hematology/Oncology and Stem Cell Therapy|March 27, 2012
A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanesH Kohail, S Shehata, O Mansour, et al.
Nutritional Neuroscience|November 29, 2021
Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter studyAmr Hassan, Nahla Merghany, Fatima Ouchkat, et al.
Neuropharmacology|May 18, 2024
Corrigendum to "Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways" [Neuropharmacol. (2021) 1, 197, 108738]Shaimaa S Ibrahim, Omar G Abo Elseoud, Mohamed H Mohamedy, et al.
Neuropharmacology|August 2, 2021
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathwaysShaimaa S Ibrahim, Omar G Abo Elseoud, Mohamed H Mohamedy, et al.
Therapeutics and Clinical Risk Management|August 18, 2020
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized ApproachSherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, et al.
Journal of Pain Research|March 27, 2020
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and CharacterizationAlaa Elmazny, Sherif M Hamdy, Maged Abdel-Naseer, et al.
Neuropsychiatric Disease and Treatment|March 6, 2018
Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patientsSherif M Hamdy, Maged Abdel-Naseer, Nevin M Shalaby, et al.
Therapeutics and Clinical Risk Management|September 5, 2020
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic EraSherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, et al.
Journal of Movement Disorders|June 25, 2024
Pain Characteristics of Parkinson's Disease Using Validated Arabic Versions of the King's Parkinson's Disease Pain Scale and Questionnaire: A Multicenter Egyptian StudyAli Shalash, Salma R Mohamed, Marwa Y Badr, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
BMC Neurology|February 4, 2021
The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in EgyptNirmeen A Kishk, Walaa Abdelfattah, Nevin M Shalaby, et al.
Hematology/Oncology and Stem Cell Therapy|March 27, 2012
A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines with/without taxanesH Kohail, S Shehata, O Mansour, et al.
Nutritional Neuroscience|November 29, 2021
Impact of Ramadan fasting on disease activity in patients with multiple sclerosis: a multicenter studyAmr Hassan, Nahla Merghany, Fatima Ouchkat, et al.
Neuropharmacology|May 18, 2024
Corrigendum to "Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways" [Neuropharmacol. (2021) 1, 197, 108738]Shaimaa S Ibrahim, Omar G Abo Elseoud, Mohamed H Mohamedy, et al.
Neuropharmacology|August 2, 2021
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathwaysShaimaa S Ibrahim, Omar G Abo Elseoud, Mohamed H Mohamedy, et al.
Therapeutics and Clinical Risk Management|August 18, 2020
Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized ApproachSherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, et al.
Journal of Pain Research|March 27, 2020
Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and CharacterizationAlaa Elmazny, Sherif M Hamdy, Maged Abdel-Naseer, et al.
Neuropsychiatric Disease and Treatment|March 6, 2018
Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patientsSherif M Hamdy, Maged Abdel-Naseer, Nevin M Shalaby, et al.
Therapeutics and Clinical Risk Management|September 5, 2020
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic EraSherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, et al.
Journal of Movement Disorders|June 25, 2024
Pain Characteristics of Parkinson's Disease Using Validated Arabic Versions of the King's Parkinson's Disease Pain Scale and Questionnaire: A Multicenter Egyptian StudyAli Shalash, Salma R Mohamed, Marwa Y Badr, et al.
Pageof 9